Tag: Vivian Berlin
-
Nation & World
‘Any patient with any disease’
Developed through Harvard’s Blavatnik Biomedical Accelerator, an innovative immune-silent stem cell technology could lead to novel cell therapies to treat “any patient with any disease.”
-
Nation & World
Beam Therapeutics receives Harvard license
Harvard University has granted a worldwide license to Beam Therapeutics Inc. to develop and commercialize a suite of revolutionary DNA base editing technologies for treating human disease.